Sign In
Buy CCEL
$3.42
+0.0600 (+1.79%)
At Close: Jul 31, 2026
Contrasting Cryo-Cell International (CCEL) & Its Rivals
09:06am, Friday, 26'th Nov 2021 Dakota Financial News
Cryo-Cell International (OTCMKTS: CCEL) is one of 30 public companies in the Miscellaneous health & allied services, not elsewhere classified industry, but how does it contrast to its rivals? We will compare Cryo-Cell International to related companies based on the strength of its risk, dividends, earnings, valuation, institutional ownership, analyst recommendations and profitability. Volatility & []
Critical Comparison: Cryo-Cell International (CCEL) versus Its Peers
01:08pm, Monday, 22'nd Nov 2021 Transcript Daily
Cryo-Cell International (OTCMKTS: CCEL) is one of 30 publicly-traded companies in the Miscellaneous health & allied services, not elsewhere classified industry, but how does it contrast to its competitors? We will compare Cryo-Cell International to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, dividends and institutional ownership. Volatility and []
Cryo-Cell International (CCEL) vs. Its Peers Critical Survey
08:44am, Monday, 22'nd Nov 2021 Transcript Daily
Cryo-Cell International (OTCMKTS: CCEL) is one of 30 public companies in the Miscellaneous health & allied services, not elsewhere classified industry, but how does it compare to its peers? We will compare Cryo-Cell International to similar companies based on the strength of its earnings, profitability, dividends, risk, analyst recommendations, institutional ownership and valuation. Analyst Ratings []
Cryo-Cell International (CCEL) vs. Its Peers Critical Contrast
06:10am, Monday, 22'nd Nov 2021 Dakota Financial News
Cryo-Cell International (OTCMKTS: CCEL) is one of 30 public companies in the Miscellaneous health & allied services, not elsewhere classified industry, but how does it contrast to its competitors? We will compare Cryo-Cell International to related companies based on the strength of its valuation, dividends, profitability, analyst recommendations, earnings, risk and institutional ownership. Analyst Recommendations []
Financial Survey: Cryo-Cell International (CCEL) versus Its Rivals
04:28pm, Friday, 19'th Nov 2021 Transcript Daily
Cryo-Cell International (OTCMKTS: CCEL) is one of 30 publicly-traded companies in the Miscellaneous health & allied services, not elsewhere classified industry, but how does it compare to its competitors? We will compare Cryo-Cell International to related businesses based on the strength of its profitability, analyst recommendations, earnings, risk, valuation, institutional ownership and dividends. Institutional and []
Reviewing Cryo-Cell International (CCEL) and Its Competitors
08:48am, Friday, 19'th Nov 2021 Dakota Financial News
Cryo-Cell International (OTCMKTS: CCEL) is one of 30 public companies in the Miscellaneous health & allied services, not elsewhere classified industry, but how does it weigh in compared to its competitors? We will compare Cryo-Cell International to related businesses based on the strength of its risk, institutional ownership, profitability, dividends, analyst recommendations, valuation and earnings. []
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
04:36pm, Friday, 15'th Oct 2021
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and sto
Cryo-Cell International Announces Changes To Its Board of Directors
06:05pm, Monday, 20'th Sep 2021
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
09:00am, Monday, 30'th Aug 2021
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Na
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
09:04am, Friday, 20'th Aug 2021
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.
Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021
12:03pm, Wednesday, 11'th Aug 2021
Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual In
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results
07:27pm, Thursday, 15'th Jul 2021
OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store
Cryo-Cell International: Overlooked Duke Contract Signals Business Inflection
02:05pm, Friday, 25'th Jun 2021
CCEL is undervalued, given the overlooked Duke contract.
IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP announces that it is investigating claims against Cryo-Cell International, Inc. (“Cryo-Cell” or the “Company”) (OTC MKTS: CCEL). The investig
LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC announces it is investigating claims against Cryo-Cell International, Inc. (“Cryo-Cell” or the “Company”) (OTC MKTS: CCEL) concerning possible viola
